Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | VERU | Common Stock | Sale | -$9.02K | -6.5K | -0.09% | $1.39 | 7.01M | May 22, 2024 | Direct | F1, F2 |
transaction | VERU | Common Stock | Sale | -$405 | -300 | 0% | $1.35 | 7.01M | May 23, 2024 | Direct | F1 |
transaction | VERU | Common Stock | Sale | -$78.1K | -63.4K | -0.9% | $1.23 | 6.94M | May 24, 2024 | Direct | F1, F3 |
holding | VERU | Common Stock | 144K | May 22, 2024 | Footnote | F4 |
Id | Content |
---|---|
F1 | Dr. Steiner sold the shares referenced above to help address certain personal matters. The sold shares represent only 0.7% of Dr. Steiner's total beneficial ownership in the Company. After these sales, Dr. Steiner will beneficially own 9,615,996 shares, and will continue to be the Company's second largest shareholder. |
F2 | The price reported above is the weighted average transaction price. The range of prices for such transactions is $1.38 to $1.40. Upon request by the Commission staff, the reporting person will provide full information regarding the number of shares sold at each separate price. |
F3 | The price reported above is the weighted average transaction price. The range of prices for such transactions is $1.22 to $1.27. Upon request by the Commission staff, the reporting person will provide full information regarding the number of shares sold at each separate price. |
F4 | Shares are held by four individual trusts with each trust for the benefit of an adult child of the reporting person. The reporting person is the trustee of each of the trusts. The reporting person disclaims beneficial ownership of these shares, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner of these shares for purposes of Section 16 or any other purpose. |